Gastrointestinal stromal tumor: Role of surgery and immunotherapy
Open Access
- 1 January 2010
- journal article
- case report
- Published by Medknow in Journal of Indian Association of Pediatric Surgeons
- Vol. 15 (4) , 148-50
Abstract
Report of a gastrointestinal stromal tumor in an 11-year-old girl who presented with a large lump in the upper abdomen. After complete surgical excision and histopathology, postoperative immunotherapy with imatinib led to an excellent outcome and a tumor-free survival of 3 years.Keywords
This publication has 14 references indexed in Scilit:
- Molecular Characterization of Pediatric Gastrointestinal Stromal TumorsClinical Cancer Research, 2008
- Pediatric KIT–Wild-Type and Platelet-Derived Growth Factor Receptor α–Wild-Type Gastrointestinal Stromal Tumors Share KIT Activation but not Mechanisms of Genetic Progression with Adult Gastrointestinal Stromal TumorsCancer Research, 2007
- Gastrointestinal Stromal Tumours: Consensus Statement on Diagnosis and TreatmentCanadian Journal of Gastroenterology and Hepatology, 2006
- Gastrointestinal Stromal Tumors in Children and Young AdultsJournal of Pediatric Hematology/Oncology, 2005
- Gastrointestinal stromal tumors arising from the stomach: A report of three childrenJournal of Pediatric Surgery, 2004
- Gastrointestinal stromal tumors (GIST): A model for molecule‐based diagnosis and treatment of solid tumorsCancer Science, 2003
- Approval summary: imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors.2002
- Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal TumorsNew England Journal of Medicine, 2002
- Effect of the Tyrosine Kinase Inhibitor STI571 in a Patient with a Metastatic Gastrointestinal Stromal TumorNew England Journal of Medicine, 2001
- Two Hundred Gastrointestinal Stromal TumorsAnnals of Surgery, 2000